Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 13/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.34 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17171646 | 0.94 | P2RX4 (0.39) | P2RX4NPSR1P2RX1P2RX3MAPT | |
| SCHEMBL11311521 | 0.90 | P2RX4 (0.46) | P2RX4NPSR1CES2ALDH1A1BCHE | |
| SCHEMBL17171665 | 0.89 | P2RX4 (0.36) | P2RX4NPSR1MAPTSMN1; SMN2ALOX5 | |
| SCHEMBL22964978 | 0.88 | P2RX4 (0.44) | P2RX4NPSR1CES2ALDH1A1BCHE | |
| SCHEMBL1573992 | 0.88 | P2RX4 (0.47) | P2RX4NPSR1CES2ALDH1A1BCHE | |
| SCHEMBL29379993 | 0.88 | P2RX4 (0.47) | P2RX4NPSR1CES2ALDH1A1BCHE | |
| SCHEMBL29406608 | 0.88 | P2RX4 (0.47) | P2RX4NPSR1CES2ALDH1A1BCHE | |
| SCHEMBL17171650 | 0.85 | P2RX4 (0.35) | P2RX4NPSR1CES2ALDH1A1BCHE | |
| SCHEMBL15434923 | 0.84 | ALDH1A1 (0.35) | P2RX4NPSR1ALDH1A1P2RX1P2RX3 | |
| SCHEMBL14244249 | 0.82 | P2RX4 (0.47) | P2RX4NPSR1P2RX1P2RX3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10622567-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2020-04-14 | — | — | US | disclosed |
| EP-2872589-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-07-26 | — | — | EP | disclosed |
| EP-2872589-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-07-26 | — | — | EP | disclosed |
| US-20150295186-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-10-15 | — | — | US | disclosed |
| US-20150295186-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-10-15 | — | — | US | disclosed |
| US-20150295186-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-10-15 | — | — | US | disclosed |
| WO-2014008967-A2 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150295186-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, EPCAM, OR10J3 | P2RX4 1560/4885NPSR1 2352/4885CES2 192/4885 |
| US-10622567-B2 | Materials for organic electroluminescent devices | L1CAM, EPCAM, OR10J3 | P2RX4 1560/4885NPSR1 2352/4885CES2 192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.